# Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia

> **NCT01867190** · PHASE2 · COMPLETED · sponsor: **Lifecells, LLC.** · enrollment: 24 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **BIOLOGICAL:** ASCT01 (Autologous Stem Cell Transplantation)

## Key facts

- **NCT ID:** NCT01867190
- **Lead sponsor:** Lifecells, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867190, "Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01867190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*